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Histone 3 Lys27 (H3K27) trimethyltransferase Ezh2 is implicated in the pathogenesis of autoimmune inflammation. 
Nevertheless, the role of Ezh2 in macrophage/microglial activation remains to be defined. In this study, we identified 
that macrophage/microglial H3K27me3 or Ezh2, rather than functioning as a repressor, mediates toll-like receptor (TLR)-
induced proinflammatory gene expression, and therefore Ezh2 depletion diminishes macrophage/microglial activation 
and attenuates the autoimmune inflammation in dextran sulfate sodium–induced colitis and experimental autoimmune 
encephalomyelitis. Mechanistic characterizations indicated that Ezh2 deficiency directly stimulates suppressor of cytokine 
signaling 3 (Socs3) expression and therefore enhances the Lys48-linked ubiquitination and degradation of tumor necrosis 
factor receptor–associated factor 6. As a consequence, TLR-induced MyD88-dependent nuclear factor κB activation 
and the expression of proinflammatory genes in macrophages/microglia are compromised in the absence of Ezh2. The 
functional dependence of Ezh2 for Socs3 is further illustrated by the rescue experiments in which silencing of Socs3 restores 
macrophage activation and rescues autoimmune inflammation in macrophage/microglial Ezh2-deficient mice. Together, 
these findings establish Ezh2 as a macrophage lineage-specific mediator of autoimmune inflammation and highlight a 
previously unknown mechanism of Ezh2 function.
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Introduction
Macrophages, the most plastic cells within the hematopoietic 
system, exert diversified functions such as maintaining homeo-
stasis, tissue repair, and immune regulation (Gordon and Taylor, 
2005; Schulz et al., 2012; Wynn et al., 2013; Ginhoux et al., 2016). 
When tissues are damaged after infection or injury, peripheral 
and tissue-resident macrophages are rapidly motivated and 
exhibit a proinflammatory phenotype (Geissmann et al., 2010; 
Nathan and Ding, 2010) and contribute to disease progression in 
many autoimmune diseases such as colitis and multiple sclerosis 
(Ponomarev et al., 2005; Friese and Fugger, 2007; Gelderman et 
al., 2007; Kamada et al., 2008; Platt et al., 2010). Microglia are a 
type of resident macrophage within the central nervous system 
(CNS; Ginhoux et al., 2010; Saijo and Glass, 2011) and play critical 
roles during the pathogenesis of multiple sclerosis and its ani-
mal model, experimental autoimmune encephalomyelitis (EAE; 
Heppner et al., 2005; Ponomarev et al., 2005, 2011; Friese and 
Fugger, 2007). We and others have demonstrated that inhibition 
of microglial activation suppressed the induction of autoimmune 
inflammation in the CNS (Heppner et al., 2005; Ponomarev et al., 
2011; Xiao et al., 2013).
The pattern-recognition receptors–induced signal 
transduction pathways are the major initiator for the activation 
of macrophages/microglia. The TLR family is one of the best-
characterized pattern-recognition receptor families that highly 
expresses on macrophages/microglia, recognizing various 
microbial components or endogenous damage-associated 
molecular patterns released from apoptotic cells or wounded 
tissues during the course of autoimmune inflammation (Akira et 
al., 2006; Prinz et al., 2006; Kawai and Akira, 2007; Gambuzza et 
al., 2011). After stimulation by their ligands, TLRs elicit cascades of 
signaling events in macrophages/microglia that lead to activation 
of NF-κB, activator protein 1, and IFN regulatory factors. These 
transcription factors act cooperatively to induce the expression 
of multiple genes involved in inflammatory responses (Akira 
Correspondence to Yichuan Xiao: ycxiao@ sibs .ac .cn; Jun Qin: qinjun@ sibs .ac .cn. 
© 2018 Zhang et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the 
publication date (see http:// www .rupress .org/ terms/ ). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 
International license, as described at https:// creativecommons .org/ licenses/ by -nc -sa/ 4 .0/ ).
1The Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of 
Chinese Academy of Sciences, Shanghai, China; 2The Key Laboratory of Stem Cell Biology, Chinese Academy of Sciences Center for Excellence in Molecular Cell 
Science, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 
China; 3Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China; 4School of Laboratory Medicine, Xinxiang Medical University, 
Xinxiang, China; 5State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, 
China; 6Department of Medicine, Section of General Pathology, University of Verona, Verona, Italy; 7Life Sciences Institute, Zhejiang University, Hangzhou, China.
on March 8, 2019jem.rupress.org Downloaded from 
http://doi.org/10.1084/jem.20171417Published Online: 6 April, 2018 | Supp Info: 
Zhang et al. 
Macrophage/microglia Ezh2 mediates autoimmunity
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20171417
1366
et al., 2006). In particular, the TLR pathway that is dependent 
on the myeloid differentiation response factor MyD88, which 
transduces signal cascades from all the TLRs except TLR3, is 
critical for the induction of autoimmune inflammation such 
as inflammatory bowel disease (Asquith et al., 2010) and EAE 
(Miranda-Hernandez et al., 2011). TRAF6, a member of the TNF 
receptor–associated factor (TRAF) family, functions as a shared 
adaptor to mediate the signal transduction of MyD88-dependent 
pathway to activate NF-κB and MAPKs (Lomaga et al., 1999; 
Takeda and Akira, 2004; Kawai and Akira, 2007).
The epigenetic regulation has emerged as one of the key 
mechanisms of controlling proper gene expression (Medzhitov 
and Horng, 2009). The methylation of histone 3 Lys27 (H3K27) 
is mediated by the polycomb repressive complex-2 (PRC2), 
composed of Ezh2, Suz12, and Eed, and is linked to the silencing 
of gene expression (De Santa et al., 2007; Schuettengruber et al., 
2007; Wei et al., 2009). In particular, Ezh2 is a key component 
of PRC2 mediating H3K27 trimethylation (H3K27me3) and has 
been suggested to play important roles in regulating immune cell 
functions (Su et al., 2003; Mandal et al., 2011; Tumes et al., 2013; 
Gunawan et al., 2015). In this study, we uncovered that inhibiting 
H3K27me3 or Ezh2 deficiency attenuates the inflammatory 
responses in macrophages, leading to the suppression of 
autoimmune inflammation. We also provide molecular and 
genetic evidence that Ezh2 serves as a negative regulator of 
suppression of cytokine signaling 3 (Socs3), which in turn 
promotes the Lys48-linked ubiquitination and degradation 
of TRAF6, therefore mediating the activation of TLR-induced 
MyD88-dependent signaling pathway.
Results
H3K27me3 inhibition specifically suppresses 
MyD88-dependent proinflammatory responses in 
macrophages/microglia
To study the role of H3K27me3 on macrophage/microglial 
activation, we examined the effect of GSK126, a selective 
Ezh2 inhibitor that inhibits H3K27me3, on TLR-mediated 
gene induction in primary cultured bone marrow–derived 
macrophages or microglia. The results revealed that GSK126 
neither alters the expression of surface cell markers (CD11b, 
F4/80) nor affects the cell viability of macrophages and microglia 
(Fig. 1, A–D), whereas it indeed suppressed the trimethylation of 
H3K27 without affecting Ezh2 protein levels in macrophages 
and microglia with or without TLR ligand stimulation (Fig.  1, 
E and F). In addition, we detected significantly reduced mRNA 
expression of proinflammatory genes such as Il6, Il12b, Tnf, 
Ccl2, and Cxcl10 and suppressed production of these cytokine/
chemokine proteins in GSK126-treated macrophages stimulated 
with TLR4 ligand LPS, TLR9 ligand CpG (Fig.  1, G and H), or 
TLR1/2 ligand Pam3Csk4 (data not depicted) compared with that 
of DMSO-treated cells. In contrast, TLR3 ligand polyinosinic: 
polycytidylic acid (poly I:C) induced comparable expression 
of proinflammatory genes at both mRNA and protein levels 
in DMSO- or GSK126-treated macrophages (Fig.  1, G and H). 
Consistently, GSK126 treatment also impaired LPS-induced 
proinflammatory gene expression at both mRNA and protein 
levels in primary cultured microglia (Fig. 1, I and J). These results 
suggest that H3K27me3 or Ezh2 specifically mediates TLR-
induced MyD88-dependent proinflammatory gene expression 
in peripheral macrophages and microglia.
Ezh2 deficiency in peripheral macrophages suppresses dextran 
sulfate sodium–induced colitis
To further assess the role of Ezh2 in macrophages, we crossed 
the Ezh2f/f mice (Su et al., 2003) with mice expressing Cre 
recombinase from the myeloid cell lineage-specific lysozyme M 
promoter (LysM-Cre) to generate mice with conditional deletion 
of Ezh2 in myeloid cells such as macrophages and microglia (Ezh2f/
fLysM-Cre, hereafter called Ezh2M−/−; Fig.  2  A). Immunoblot 
analysis revealed specifically the loss of Ezh2 protein expression 
and reduction of H3K27me3 in macrophages of the Ezh2M−/− 
mice (Fig.  2  B). The Ezh2M−/− mice were born at the expected 
Mendelian ratio and exhibited normal growth and survival. 
The development and maturation of myeloid cells appeared 
to be normal, because Ezh2M−/− mice and their WT littermates 
produced similar frequencies of macrophages, neutrophils, 
and dendritic cells in bone marrow and spleens (Fig. 2, C–F). In 
addition, Ezh2 deficiency in myeloid cells did not affect T cell 
development in thymus and the maturation and activation of 
peripheral lymphoid cells (data not depicted; Fig. 2, G–I).
To investigate the in vivo function of Ezh2 in regulating 
peripheral macrophage-mediated autoimmune inflammation, 
WT and Ezh2M−/− mice were challenged with 3% dextran sulfate 
sodium (DSS) to induce a colitis model, which is commonly 
used to study the innate immune cell function (Chassaing et al., 
2014) and mimic human autoimmune disease inflammatory 
bowel disease. In Ezh2M−/− mice, we confirmed the deletion 
deficiency of Ezh2 both in colonic and splenic macrophages 
(Fig. 3 A). In addition, macrophage-specific deficiency of Ezh2 
did not affect the morphological and histological features of 
the colon, whereas it significantly inhibited the susceptibility 
of  DSS-induced colitis, characterized by significantly less 
body-weight loss, longer colons, and reduced inflammatory 
infiltration with a less severe disruption of  the mucosal 
epithelium in response to DSS treatment compared with 
WT control cohorts (Fig.  3, B–E). Consistently, we detected 
comparable frequencies and absolute numbers of  colon-
resident immune cells in naive WT and Ezh2M−/− mice (Fig. 3, 
F and G) and similar frequencies and numbers of  blood-
circulating immune cells in DSS-challenged WT and Ezh2M−/− 
mice (Fig. 3, H and I). In contrast, the frequencies and absolute 
numbers of  colon-infiltrating total immune cells (CD45+), 
CD4+, and CD8+ T cells, macrophages (CD11b+F4/80+), and 
neutrophils (CD11b+Gr-1+) in Ezh2M−/− mice were dramatically 
reduced compared with those in WT mice after DSS challenge 
(Fig.  3, J–L). Accordingly, quantitative RT-PCR (qRT-PCR) 
assays revealed the reduced expression of proinflammatory 
cytokine genes in the colon-infiltrating macrophages of the 
Ezh2M−/− mice (Fig.  3  M). Moreover, we found that in the 
absence of neutrophils, Ezh2 deficiency in macrophages alone 
still suppressed the weight loss in colitis mice (Fig. 3, N–Q). 
Thus, these results establish Ezh2 as a pivotal mediator of 
colitis that functions in peripheral macrophages.
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Microglia Ezh2 facilitates CNS autoimmune inflammation
To examine the role of Ezh2 in tissue-resident macrophages 
such as microglia, we immunized WT and Ezh2M−/− mice with a 
myelin oligodendrocyte glycoprotein (MOG) peptide (MOG35–55) 
along with pertussis toxin to induce CNS autoimmunity model 
EAE, in which microglia are critical for the disease initiation 
and progression (Heppner et al., 2005; Chastain et al., 2011; 
Gao and Tsirka, 2011; Ponomarev et al., 2011; Xiao et al., 2013). 
As expected, the WT mice developed severe clinical symptoms 
that were characterized by a gradual increase in the severity of 
paralysis (Fig. 4 A), inflammatory cell infiltration into the CNS, 
and demyelination (Fig. 4 B). Despite the competent responses of 
T cells in the Ezh2M−/− mice to antigen stimulation (Fig. S1, A–F), 
Ezh2 mutant mice displayed decreased incidence of EAE, and if 
EAE developed, the symptom was significantly milder as indi-
cated by lower clinical scores (Fig. 4, A and B). Likewise, Ezh2M−/− 
mice displayed reduced frequencies and numbers of CNS-in-
filtrating T cells (CD4+ and CD8+), myeloid cells, and activated 
resident microglial cells (CD11b+CD45hi) and total lymphocytes 
(CD11b−CD45hi) with a concomitant increase in the frequency 
and number of resting microglial cells (CD11b+CD45lo; Fig. 4, C 
and D). In addition, the absolute numbers of IL-17+ Th17 cells and 
IFN-γ+ Th1 cells among the CD4+ T cells infiltrating the CNS were 
significantly lower in Ezh2M−/− mice than that in Ezh2-sufficient 
mice (Fig. 4, E and F).
To determine whether Ezh2 deficiency in peripheral myeloid 
cells contributes to the suppression of EAE, the radiation bone 
marrow chimeric mice were generated by reconstituting lethally 
irradiated WT mice with bone marrow cells isolated from WT 
or Ezh2M−/− mice. We observed comparable EAE disease scores 
between these two chimeric mice (Fig. 4 G). In contrast, a reverse 
bone marrow transfer experiment by reconstituting lethally 
irradiated WT or Ezh2M−/− mice with WT bone marrow cells 
isolated from B6/SJL-transgenic mice (cells expressing CD45.1 
congenic marker) revealed that the WT SJL-chimeric mice were 
highly susceptible to EAE induction, whereas the Ezh2-deficienct 
SJL-chimeric mice were refractory (Fig. 4 H). Additionally, the 
recruitment of peripheral CD45.1+ leukocytes into the CNS of 
Ezh2-deficienct SJL-chimeric mice was inhibited compared with 
that of WT control mice (Fig. 3 I). Thus, Ezh2 in radioresistant 
microglia but not in peripheral myeloid cells participated in the 
pathogenesis of EAE.
To further confirm the pathological role of Ezh2 in microglia 
to mediate EAE pathogenesis, we crossed the Ezh2f/f mice with 
Cx3cr1-CreER-EYFP mice to generate microglia-conditional 
Ezh2-knockout (hereafter called Ezh2Mg−/−) mice (Fig. S1 G). 
By using the tamoxifen-inducible system, Ezh2 is specifically 
deleted in microglia of Ezh2Mg−/− mice because microglia persist 
throughout the entire life of the organism, whereas short-lived 
blood monocytes are replaced by their WT monocyte progeny 
within 1 mo (Fig. S1 H; Goldmann et al., 2013). The Ezh2Mg−/− mice 
and their WT littermates were treated with tamoxifen, and 1 mo 
later we observed specific deletion of Ezh2 in CNS microglia but 
not in splenic macrophages in Ezh2Mg−/− mice (Fig. 4 J and Fig. S1 
I), which were then immunized with MOG35-55 to induce EAE. We 
found that mice with specific deletion of Ezh2 in microglia dis-
played significantly delayed onset and reduced severity of EAE 
disease, as well as substantially less infiltration of immune cells 
into the CNS, relative to that of their Ezh2-sufficient counterparts 
(Fig. 4, K and L). Moreover, The Ezh2-deficient microglia that 
isolated from EAE-induced Ezh2-deficient SJL-chimera mice, in 
which monocyte-derived macrophages are CD45.1+CD11b+ cells 
and radioresistant CNS microglia are CD45.1−CD11b+ cells, also 
exhibited impaired expression of proinflammatory cytokine 
and chemokine genes (Fig. 4 N). These data collectively suggest a 
microglia-specific role for Ezh2 in mediating CNS autoimmune 
inflammation and EAE induction.
Ezh2 mediates MyD88-dependent inflammatory responses in 
macrophages/microglia
To dissect the mechanistic role of Ezh2 in macrophage/microg-
lia-mediated autoimmune inflammation, we conducted gene 
expression profile analysis using WT and Ezh2-deficient bone 
marrow–derived macrophages. Gene ontology (GO) analysis 
revealed the most prominent biological processes altered in mac-
rophages upon LPS stimulation were associated with immune 
system process (Fig. 5 A), and the heat map results summarized 
that Ezh2 deficiency impaired LPS-induced proinflammatory 
cytokines and chemokines gene expression (Fig. 5 B). Consistent 
with H3K27me3 inhibition data, quantitative RT–PCR assays 
confirmed that Ezh2 deficiency severely attenuated proinflam-
matory gene induction by MyD88-dependent TLR ligands but 
not TLR3-induced gene expression (Fig. 5 C and Fig. S2 A). Sim-
ilar results were obtained by ELI SA assessing the production of 
secreted cytokines (Fig. 5 D) and by qRT-PCR analysis of primary 
cultured microglia that stimulated with the TLR4 ligand LPS and 
TLR1/2 ligand Pam3Csk4 (Fig.  5  E and Fig. S2 B). In addition, 
the role of Ezh2 in mediating TLR-induced gene expression was 
dependent on its C-terminal methyltransferase SET domain, 
because stable expression of WT Ezh2, but not the empty lenti-
viral vector (EV) control protein or a SET domain deleted Ezh2 
mutant, Ezh2ΔSET, restored H3K27me3 and the LPS-induced 
gene expression in the Ezh2-KO BV2 microglia cells (Fig. 5 F). 
These results establish Ezh2 as a pivotal methyltransferase that 
Figure 1. GSK126 suppresses MyD88-dependent proinflammatory responses in macrophages/microglia. (A–D) Flow cytometry of the surface CD11b 
and F4/80 expression and MTT analysis of primary cultured bone marrow–derived macrophages (A and B) or microglia (C and D) that were pretreated with 
DMSO or GSK126 (4 µM) for 3 d. (E–G and I) Immunoblot analysis (E and F) of Ezh2, H3K27me3, H3, and Hsp60 (loading control) in whole-cell lysates and real-time 
qRT-PCR analysis (G and I) of the indicated proinflammatory genes of macrophages (E and G) or microglia (F and I) that were pretreated with DMSO or GSK126 
(4 µM) for 3 d and then left nontreated (NT) or stimulated for 6 h with the ligands of different TLRs: TLR4 (LPS, 100 ng/ml), TLR9 (CpG, 2.5 µM), and TLR3 (pI:C, 20 
µg/ml). (H and J) ELI SA showing the production of indicated proinflammatory cytokines/chemokines in the culture supernatants of macrophages (H) or microglia 
(J) that were pretreated with DMSO or GSK126 (4 µM) for 3 d and then left nontreated (NT) or treated for 24 h with the indicated TLR ligands. The qRT-PCR data 
were normalized to a reference gene Actb (β-actin), and other data were shown as mean ± SD based on three independent experiments. *, P < 0.05; **, P < 0.01 
determined by Student’s t test or two-way ANO VA with post hoc test.
Zhang et al. 
Macrophage/microglia Ezh2 mediates autoimmunity
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20171417
1369
mediates MyD88-dependent proinflammatory responses specif-
ically in peripheral macrophages and microglia.
Ezh2 epigenetically controls Socs3 expression in 
macrophages/microglia
Previous studies have suggested that Ezh2-mediated H3K27me3 
is associated with gene transcriptional silencing (De Santa et al., 
2007; Schuettengruber et al., 2007; Wei et al., 2009). However, 
Ezh2 deficiency or H3K27me3 inhibition impaired proinflam-
matory gene expression in macrophages/microglia, and we rea-
soned that Ezh2 may control the production of antiinflammatory 
mediators to regulate the macrophage/microglial activation and 
autoimmune inflammation. Indeed, when the cells were pre-
treated with protein synthesis inhibitor cycloheximide, the 
expression of TLR-induced proinflammatory genes was compa-
rable between WT and Ezh2-deficient macrophages (Fig. 6 A). 
To identify the potential antiinflammatory genes that are reg-
ulated by Ezh2-mediated H3K27me3, we immunoprecipitated 
chromatin from WT macrophages stimulated with or without 
LPS and analyzed the precipitated DNA with deep chromatin 
immunoprecipitation (ChIP) sequencing (ChIP-Seq). In line 
with the roles of EZH2 in the regulation of gene transcriptions, 
annotation of the peak in genomic positions to the closest genes 
demonstrated that many peaks were positioned immediately 
Figure 2. Ezh2 deficiency neither affects the development and maturation of myeloid cells nor influences the activation of peripheral lymphoid cells. 
(A) Genotyping PCR analysis of tail DNA from Ezh2f/f, Ezh2+/+, Ezh2f/+, and LysM-cre mice. (B) Immunoblot analysis of Ezh2, H3K27me3, H3, and Hsp60 in bone 
marrow macrophages and splenocytes from Ezh2f/f LysM-cre− (WT) and Ezh2f/f LysM-cre+ (Ezh2M−/−) mice. (C–F) Flow cytometry analysis of CD11b+F4/80+ 
macrophages (Ma), CD11b+Gr-1+ neutrophils (Neu), total CD11c+ DCs (DCs), CD11c+B220− conventional dendritic cells (cDCs), and CD11c+B220+ plasmacytoid 
dendritic cells (pDCs) in bone marrow (C and D) and in spleen (E and F) from WT and Ezh2M−/− mice. Data are presented as representative plots (C and E) and 
summary graphs (D and F). (G–I) Flow cytometry analysis of the cell numbers of total CD4+ and CD8+ T cells, CD4+ and CD8+ memory (CD62LlowCD44hi) and 
naive (CD62LhiCD44low) T cells, and CD4+CD25+Foxp3+ regulatory T (Treg) cells in spleen (G), PLN (peripheral lymph node; H), and MLN (mesenteric lymph 
node; I) from WT and Ezh2M−/− mice. The data are shown as mean ± SD based on three independent experiments. *, P < 0.05; **, P < 0.01 determined by 
Student’s t test.
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after the transcription start site (TSS). Intriguingly, we also 
noticed LPS treatments greatly attenuated Ezh2 binding in the 
mouse genome (Fig. 6, B and C), suggesting that reductions of 
Ezh2 occupancies in the subset of genes might be required for 
LPS-induced inflammatory gene transcriptions. Focusing on 
LPS-treated macrophages, we identified 5,077 genes harboring 
Ezh2 occupancies within the core transcription regions (−3 to 3 
kb from TSS; Fig. 6, B–D). To correlate chromatin binding with 
direct gene regulations, we integrated the Ezh2-dependent tran-
scriptome with a primary focus on the genes displaying up-reg-
ulation in the absence of Ezh2. Among this group of 1,827 genes, 
vein diagrams indicated there were ∼395 genes harboring Ezh2 
occupancies as well (Fig. 6 D), suggesting they might be directly 
regulated by Ezh2.
Among these genes, we selected the most up-regulated genes 
that may also modulate macrophage function based on reported 
data, through which several candidate genes, including PPAR-γ, 
ATF3, Sphk1, and Socs3, were chosen for further analysis. Inter-
estingly, we identified Socs3, a previously known antiinflam-
matory gene, harbored several Ezh2 intervals near the TSS and 
distal enhancer regions (Fig. 6 E). Such occupancies of Ezh2 in 
the Socs3 gene locus were validated by ChIP coupled with quanti-
tative PCR (ChIP-qPCR) assays (Fig. 6 F). Indeed, we detected both 
mRNA and protein levels of Socs3 were significantly increased in 
Ezh2-deficient macrophages and BV2 microglial cells compared 
with those of WT cells (Fig. 6, G and H). Accordingly, Ezh2 deple-
tion caused a substantial reduction of H3K27me3 levels both at 
the TSS proximal region and distal enhancer, whereas the his-
tone markers of H3K4me3 were further enhanced at the distal 
enhancer in comparison with control cells as predicted (Fig. 6, I 
and J). Collectively, these results establish Socs3, an antiinflam-
matory gene, as a direct target that is fine-tuned by Ezh2-medi-
ated H3K27me3 in macrophages/microglia.
Ezh2 regulates TRAF6 degradation and its 
downstream signaling
It is reported that Socs3 directly mediates the Lys48-linked ubiq-
uitination and degradation of TRAF6 (Williams et al., 2014; Zhou 
et al., 2015), which is a critical adaptor essential for MyD88-de-
pendent TLR-induced downstream signaling activation (Lomaga 
et al., 1999; Takeda and Akira, 2004). As expected, we found that 
Ezh2 deficiency markedly promoted Lys48-ubiquitination of 
TRAF6 in Ezh2-deficient macrophages and BV2 microglial cells 
(Fig.  7, A and B). Accordingly, TRAF6 protein levels were sig-
nificantly lower in Ezh2-deficient macrophages, microglia, and 
BV2 cells compared with WT cells (Fig. 7, C–E), whereas TRAF6 
mRNA transcription was comparable between the two groups 
of cells (Fig. 7, F and G). We next examined the effect of Ezh2 
deficiency on TLR-induced activation of NF-κB and MAPK, 
which are the downstream signaling controlled by TRAF6 in 
MyD88-dependent pathway. The results revealed that loss of 
Ezh2 in macrophages impaired LPS- and Pam3CSK4-induced 
activation of NF-κB through MyD88-dependent TLR (Fig. 7, H 
and I). In contrast, Ezh2 was dispensable for NF-κB activation 
by the Trif-dependent TLR ligand poly I:C (Fig. 7 J), and Ezh2-de-
ficient macrophages did not show an appreciable defect in the 
MyD88-dependent TLR-induced activation of the MAPKs p38, 
ERK, and JNK (Fig. 7, H and I). Similarly, in microglia, Ezh2 defi-
ciency also impaired LPS-induced activation of NF-κB (Fig. 7 K). 
These data collectively establish Ezh2 as a pivotal regulator of 
TRAF6 stability, mediating MyD88-dependent NF-κB activation.
Inhibition of Socs3 restores autoimmune inflammation in 
Ezh2-deficient mice
Socs3 is an antiinflammatory gene that negatively regulates 
macrophage activation, and genetic ablation of Socs3 in myeloid 
cells aggravated the disease severity of LPS-induced septic shock 
and EAE (Qin et al., 2012a,b). To assess the functional importance 
of Ezh2-mediated Socs3 suppression in mediating macrophage 
activation and autoimmune inflammation, we knocked down 
Socs3 in WT and Ezh2-deficient macrophages. Interestingly, 
Socs3 silencing promoted LPS-induced proinflammatory 
gene expression and erased the differences between WT and 
Ezh2-deficient cells (Fig.  8  A). In addition, we found that the 
expression of Socs3 was significantly higher in colonic and 
splenic macrophages that isolated from Ezh2M−/− mice than 
that from WT mice (Fig.  8  B), which confirmed the in vivo 
function of Ezh2 deficiency in promoting Socs3 expression 
in macrophages. Expectedly, injection of the Ezh2M−/− mice 
with retrovirus carrying a Socs3-specific shRNA significantly 
suppressed Socs3 expression in both colonic and splenic CD11b+ 
macrophages (Fig.  8  B) and largely restored DSS-induced 
colitis accordingly, characterized by the increased body-weight 
loss similar to that in WT mice receiving retrovirus carrying 
control shRNA (Fig. 8 C). Meanwhile, compared with that in WT 
mice, Socs3 expression was only higher in CNS microglia but 
not in splenic macrophages of Ezh2Mg−/− mice (Fig. 8 D); Ezh2 
is specifically deleted in CNS microglia but not in peripheral 
splenic macrophages. Accordingly, knockdown of Socs3 in CNS 
microglia also significantly rescued the defects of Ezh2Mg−/− mice 
Figure 3. Ezh2 deficiency in myeloid cells suppresses DSS-induced colitis. (A) qRT-PCR analysis of Ezh2 mRNA in FACS-sorted CD11b+F4/80+macrophages 
from the colon and spleen of naive WT and Ezh2M−/− mice. (B) The body-weight loss of WT and Ezh2M−/− mice that were challenged with DSS in drinking water 
for 7 d. (C–E) The colon images (C), colon lengths (D), and representative H&E-stained images of proximal colon cross sections (E) of naive and DSS-challenged 
WT and Ezh2M−/− mice at day 12. Bars, 100 µm. (F and G) The frequencies (F) and absolute numbers (G) of the indicated immune cell populations in the colon 
of naive WT and Ezh2M−/− mice based on flow cytometry analysis. (H–L) Flow cytometry analysis of blood-circulating (H and I) and colon-infiltrated immune 
cell (J–L) of DSS-challenged WT and Ezh2M−/− mice (n = 4 mice per group) at day 6. Data are presented as representative plots (J) and summary graphs (H, I, 
K, and L). (M) qRT-PCR analysis of the indicated proinflammatory genes and Ezh2 mRNA in FACS-sorted colon infiltrated CD11b+F4/80+macrophages from 
DSS-challenged WT and Ezh2M−/− mice (n = 4 mice per group) at day 6. (N) The body-weight loss of WT and Ezh2M−/− mice that were deleted of CD11b+Gr-1+ 
neutrophils with anti-Ly6G antibody (α-Ly6G) and then challenged with DSS in drinking water for 7 d. (O–Q) Flow cytometry analysis of colon-infiltrated and 
spleen immune cells of DSS-challenged WT and Ezh2M−/− mice (n = 4 mice per group) that were deleted of neutrophils as described in N at day 6. The qRT-PCR 
data were normalized to a reference gene Actb (β-actin), and other data are shown as mean ± SD based on three independent experiments. *, P < 0.05; **, P 
< 0.01 determined by Student’s t test.
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Figure 4. Microglia Ezh2 facilitates CNS autoimmune inflammation. (A) Mean clinical scores of age- and sex-matched WT and myeloid cell Ezh2-deficient 
(Ezh2M−/−) mice after the induction of EAE with MOG35–55 (n = 5 mice per group). (B) H&E and LFB staining of spinal cord sections from MOG35–55-immunized 
WT and Ezh2M−/− mice visualizing immune-cell infiltration and demyelination (arrows), respectively. Bars, 100 µm. Magnification of enlarged images, ×100. 
(C and D) Flow cytometry analysis of immune-cell infiltration into the CNS (brain and spinal cord) of MOG35–55-immunized WT and Ezh2M−/− mice (n = 5 mice 
per group) at day 14 after immunization. Data are presented as representative plots (C) and summary graphs (D). The numbers in the plots are the percentages 
of each gated cell population among the total CNS-infiltrated cells. (E and F) Frequency and absolute number of IFN-γ– and IL-17–producing effector T cells 
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in EAE induction and in the inflammatory infiltration and 
demyelination in the CNS (Fig.  8, D–F). Collectively, these in 
vitro and in vivo studies highlight the functional importance of 
Ezh2-mediated Socs3 suppression in mediating macrophage/
microglial activation and autoimmune inflammation.
Discussion
Macrophages form a major type of innate immune cells to sense 
pathogen invasion and tissue injury, and excess production of 
proinflammatory cytokines by activated macrophages con-
tributes to the pathogenesis of autoimmune inflammation. We 
and others have shown that depletion or functional inhibition 
of macrophages exhibits promising effects in attenuating the 
severity of several autoimmune diseases (Heppner et al., 2005; 
Marshall et al., 2007; Ponomarev et al., 2011; Xiao et al., 2013). 
Thus, a large number of clinical trials were tested in autoimmune 
diseases such as colitis, multiple sclerosis, and arthritis by tar-
geting macrophage activation (Hamilton et al., 2016). Here we 
identified Ezh2 as a pivotal mediator in both peripheral macro-
phages and CNS-resident microglia, through which it regulates 
the pathogenesis of autoimmune inflammation. It is reported 
that peripheral monocyte-derived and gut-resident macrophages 
may be functionally different in modulating colitis pathogenesis 
(Zigmond et al., 2012). Nevertheless, considering the universal 
effect of Ezh2 in regulating the activation of macrophage lineage 
cells, we speculated that Ezh2 deficiency may impair the inflam-
matory responses both in peripheral monocyte-derived and 
gut-resident macrophages, which collectively contributed to the 
inhibition of colitis pathology in Ezh2M−/− mice.
Ezh2 is critical in mediating the formation of H3K27me3, 
which is associated with gene transcriptional suppression (De 
Santa et al., 2007; Schuettengruber et al., 2007; Wei et al., 2009; 
Liu et al., 2017). However, we found that Ezh2 in macrophages/
microglia exhibits opposite effects, reflected by impaired TLR-
induced proinflammatory gene expression in the absence 
of Ezh2 or H3K27me3. This effect of Ezh2 in macrophages/
microglia is due to the suppressed expression of Socs3, an 
antiinflammatory gene directly targeted by Ezh2-mediated 
H3K27me3. Additionally, Ezh2 does not affect TLR-induced 
inflammatory responses in dendritic cells (unpublished data), 
although Ezh2 deficiency in dendritic cells suppressed CNS 
autoimmunity (Gunawan et al., 2015). Thus, it is more likely 
that Ezh2 and/or H3K27me3 has a unique regulatory pattern 
specifically in macrophage lineage cells.
It is reported that the inhibitor of H3K27 demethylase Jmjd3 
repressed LPS-induced expression of proinflammatory genes in 
activated macrophages (Kruidenier et al., 2012). However, genetic 
ablation of Jmjd3 in macrophages did not affect the gene expres-
sion induced by various TLR ligands but impaired macrophage 
M2 polarization (Satoh et al., 2010). Our study demonstrates that 
the selective inhibitor or genetic ablation of Ezh2 exhibits similar 
effects in macrophages/microglia in which Ezh2 or H3K27me3 
mediate TLR-induced proinflammatory gene expression. In addi-
tion, Ezh2 deficiency also slightly impaired M2 polarization (Fig. 
S3). These data combined with published studies suggested that 
Ezh2- or Jmjd3-mediated modulation of H3K27me3 diversely 
regulates inflammatory gene expression through different 
molecular mechanisms in macrophages and that the functional 
diversity of H3K27me3 may be due to the delicate regulatory dif-
ference by its methyltransferase and demethylase. Because either 
Ezh2-mediated trimethylation or Jmjd3-mediated demethylation 
of H3K27 is a universal effect on the whole genome, it is reason-
able to speculate these two enzymes may have their preference 
to target some specific genes, resulting in functional diversity of 
macrophage activation. In T cells, Ezh2 deficiency promoted Th1/
Th2 cell differentiation in nonpolarized T cells through enhanced 
expression of Tbx21 and Gata3 (Tumes et al., 2013), implying 
a cell-specific function of Ezh2 and H3K27me3 in a different 
immune cell subset.
Previous studies have demonstrated the critical roles of 
monocyte-derived macrophages in regulating EAE pathogenesis 
in which CNS-infiltrated macrophages are highly phagocytic 
and inflammatory (Ajami et al., 2011; Yamasaki et al., 2014). 
Nevertheless, we and others have suggested that the pathogenesis 
of EAE and multiple sclerosis also involves microglia (Heppner 
et al., 2005; Chastain et al., 2011; Gao and Tsirka, 2011; 
Ponomarev et al., 2011; Xiao et al., 2013). Here we found that 
Ezh2 in monocyte-derived macrophages is dispensable for EAE 
induction by using the bone marrow chimeric EAE mouse models 
in which the bone marrow from WT and Ezh2M−/− mice exhibits 
comparable capability to induce EAE, suggesting Ezh2 does 
not directly function in peripheral macrophages to affect EAE 
disease progression, although it impairs monocyte infiltration 
in actively induced Ezh2M−/− EAE mice. However, Ezh2-specific 
deletion in microglia but not in peripheral macrophages by using 
the Ezh2Mg−/− mice significantly suppressed CNS autoimmune 
inflammation after EAE induction, which suggested a unique role 
of Ezh2 in microglia to regulate EAE pathogenesis. Therefore, 
the suppressed activation of microglia but not peripheral 
in the CNS (brain and spinal cord) of day 14 MOG35–55-immunized WT and Ezh2M−/− mice, shown as representative plots (E) and summary graphs (F). (G and 
H) Clinical scores after the induction of EAE in B6 mice that were adoptively transferred with WT or Ezh2M−/− bone marrow cells (n = 7 mice per group; G) or 
clinical scores after the induction of EAE in WT and Ezh2M−/− mice adoptively transferred with B6-SJL bone marrow cells (n = 5 mice per group; H). (I) Flow 
cytometry analysis of CNS-infiltrating immune cells of the MOG35–55-immunized WT and Ezh2M−/− SJL-chimeric mice at day 15 after immunization as described 
in H, showing a summary graph of the absolute cell numbers. (J) Immunoblot analysis of Ezh2 and Hsp60 expression in FACS-sorted CNS microglia (MG) and 
spleen CD11b+F4/80+ macrophages (Sp Mφ) from WT (Ezh2+/+Cx3cr1-creER-EYFP+) and microglia Ezh2-deficient (Ezh2Mg−/−, Ezh2f/fCx3cr1-creER-EYFP+) mice. 
(K) Mean clinical scores of age- and sex-matched WT and microglia Ezh2-deficient (Ezh2Mg−/−) mice that exposed with tamoxifen 30 d before immunization 
and then applied for EAE induction (n = 5 mice per group). (L and M) Flow cytometry analysis of immune-cell infiltration into the CNS (brain and spinal cord) of 
MOG35–55-immunized WT and Ezh2Mg−/− mice (n = 5 mice per group) at day 14 after immunization. Data are presented as representative plots (L) and summary 
graphs (M). (N) qRT-PCR analysis of the indicated genes in FACS-sorted CNS CD45.1−CD11b+ microglia of MOG35–55-immunized WT and Ezh2M−/− SJL-chimeric 
mice (n = 5 mice per group) on day 14 after immunization. The qRT-PCR data were normalized to a reference gene Actb (β-actin), and other data are shown as 
the mean ± SD based on three independent experiments. *, P < 0.05; **, P < 0.01 determined by Student’s t test.
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Figure 5. Ezh2 mediates MyD88-dependent inflammatory responses in macrophages/microglia. (A) GO term analysis of Ezh2 function in macrophages 
treated with LPS through DAV ID informatics shows that the most significantly enriched biological process is related to immune system process. (B) RNA-Seq 
analysis by using WT and Ezh2-deficient macrophages left nontreated (NT) or stimulated for 2 h with LPS, showing the heat maps of genes with adjusted P 
value <0.05, false discovery rate <0.05, and log2 fold-change >1.2 (left) and the indicated proinflammatory cytokine and chemokine genes down-regulated 
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macrophages was the reason for impaired monocyte infiltration 
and ameliorated disease severity in actively induced Ezh2M−/− 
EAE mice. In addition, a recently published microarray dataset 
suggests an elevated tendency of Ezh2 expression in the brain 
tissues of multiple sclerosis patients compared with that of control 
donors (Gene Expression Omnibus accession no. GSE32915; Fig. 
S4), implying a pathological role of Ezh2 in microglia to mediate 
the pathogenesis of human multiple sclerosis.
Socs3, a well-known antiinflammatory mediator, has 
been shown to negatively regulate TLR-induced macrophage 
activation and autoimmune inflammation (Marshall et al., 
2007; Qin et al., 2012a,b). In this study, we identified that Ezh2-
mediated H3K27me3 directly targets Socs3 for its transcriptional 
inhibition. Thus, Ezh2 deficiency elevated Socs3 expression 
in vitro and in vivo, which explains suppressed TLR-induced 
inflammatory responses in macrophages/microglia and inhibited 
autoimmune inflammation in the absence of Ezh2 or H3K27me3. 
In addition, Ezh2 deficiency impaired TLR-induced MyD88-
dependent NF-κB activation because of promoted Lys48-linked 
ubiquitination and degradation of TRAF6, which is mediated by 
the elevated expression of Socs3. We noticed that Ezh2 deficiency 
inhibited TLR-induced NF-κB activation without affecting MAPK 
activation because of decreased TRAF6 levels, implying that the 
activation of NF-κB is more sensitive to the alteration of Traf6 
levels than MAPK or there may exist other cross-talked signaling 
pathways to compensate the activation of MAPK. In addition, 
silencing of Socs3 restores TLR-induced inflammatory responses 
in Ezh2-deficient macrophages, and Socs3 shRNA retrovirus 
rescues the induction of autoimmune inflammation in both 
colitis and EAE models. Given the facts that Socs3 knockdown 
was also observed in other cell types, we cannot fully exclude the 
possibilities that Socs3 shRNA retrovirus injection may function 
in other immune cells to regulate the autoimmune inflammation 
in macrophage/microglial Ezh2-deficient mice.
In summary, our work establishes Ezh2 as a mediator 
of  macrophage/microglial activation and autoimmune 
inflammation. On the basis of our data, we propose a model 
in which Ezh2-mediated H3K27me3 directly targets and 
suppresses the expression of Socs3. Ezh2 deficiency–induced 
up-regulation of Socs3 mediates the Lys48-linked ubiquitination 
and degradation of TRAF6, leading to the suppression of TLR-
induced MyD88-dependent NF-κB activation and the inhibition 
of genes involved in macrophage/microglial activation and 
autoimmune inflammation (Fig. 9). Thus, the development of 
therapeutic strategies to specifically target Ezh2 or H3K27me3 




Ezh2 floxed mice were crossed with lysozyme M-Cre mice (LysM-
Cre; The Jackson Laboratory) to produce myeloid cell–conditional 
Ezh2 knockout mice (Ezh2flox/flox LysM-Cre; termed Ezh2M−/−) 
or with Cx3cr1-CreER-EYFP mice (The Jackson Laboratory) 
to produce microglia–conditional Ezh2 knockout mice (Ezh-
2flox/flox Cx3cr1-CreER-EYFP, termed Ezh2Mg−/−). All mice were 
maintained in a specific pathogen–free facility, and all animal 
experiments were in accordance with protocols approved by the 
institutional Biomedical Research Ethics Committee, Shanghai 
Institutes for Biological Sciences, Chinese Academy of Sciences.
Plasmids, antibodies, and reagents
Flag-Ezh2 and Flag-Ezh2ΔSET were generated by the insertion 
of cDNA encoding full-length Ezh2 and its SET domain–defi-
cient mutant (ΔSET) into pLVX-GFP vector. The control and 
Socs3 shRNA–expressing pLKO.1 plasmids were purchased 
from OriGene. Antibodies for Ezh2 (5246s), H3K27me3 (9733s), 
H3 (9715s), P-p105 (4806s), P-p65 S536 (3033s), P-p38 (9215s), 
P-IκBα (2859s), P-Jnk (4668s), and Socs3 (2932s) were purchased 
from Cell Signaling Technology. Antibodies for IκBα (sc-371), p38 
(sc-7149), Jnk1 (sc-474), Erk (sc-94), P-Erk (sc-7383), p105 (sc-
1190), p65 (sc-109), and Traf6 (sc-7221) were purchased from 
Santa Cruz Biotechnology. Lys48-Ub antibody was purchased 
from Merck Millipore. Antibodies used for flow cytometry were 
from eBioscience. The Ezh2 inhibitor GSK126 (HY-13470) was 
from MedChem Express. LPS was from Sigma Aldrich. CpG, poly 
I:C, and Pam3CSK4 were from InvivoGen.
DSS-induced colitis
To induce colitis, mice (6–8 wk old) were fed with 3% DSS (36–50 
kD; MP Biomedicals) for 7 d followed by regular drinking water. 
For the neutrophil-deletion experiment, mice were injected i.v. 
with anti–mouse Ly6G antibody (BE0075-1; Bio X Cell) at the 
dose of 100 µg/mouse starting 1 d before DSS challenge and then 
injected with the antibody another three times at 2-d intervals. 
During the experiment, body weights, stool consistency, and gas-
trointestinal bleeding were monitored daily. Mice were sacrificed 
at the indicated time points, and colons were collected immedi-
ately for measuring colon length, histology analysis, and immune 
cell isolation from the mucosa.
Induction and assessment of EAE
The induction of active EAE was as previously described (Xiao 
et al., 2013). In brief, age- and sex-matched mice (8–10 wk 
old) were injected s.c. with 200 µg MOG35–55 peptide in CFA 
in Ezh2-deficient macrophages relative to WT cells that treated with LPS for 2 h (right). The source RNA-Seq data were deposited into the Gene Expression 
Omnibus with the accession no. GSE101316. (C and E) Immunoblot analysis of Ezh2, H3K27me3, H3, and Hsp60, showing the efficiency of Ezh2 deletion and 
H3K27me3 inhibition in Ezh2-deficient macrophages (C) or microglia (E) compared with WT cells, and qRT-PCR determining the relative expression of indicated 
proinflammatory genes in macrophages (C) or microglia (E) from WT and Ezh2M−/− mice treated with LPS at the indicated time points. (D) ELI SA showing the 
production of IL-6, IL-12p40, and TNF in the culture supernatants of WT and Ezh2-deficient macrophages that were left nontreated (NT) or treated for 24 h 
with LPS. (F) qRT-PCR analysis of the indicated genes (left) and IB analysis of Ezh2, H3K27me3, H3, and Hsp60 (right) in CRI SPR/Cas9-mediated Ezh2 knockout 
BV2 microglial cells that were infected with EV or lentiviral vector encoding WT Ezh2 or its SET domain deletion mutant (ΔSET), left nontreated (NT), or treated 
for 6 h with LPS. Data were normalized to a reference gene, Actb (β-actin), and shown as mean ± SD based on three independent experiments. *, P < 0.05; **, P < 
0.01 determined by Student’s t test.
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containing 5 mg/ml heat-killed Mycobacterium tuberculosis 
H37Ra (Difco). On the day of immunization and 48 h later, the 
mice were also injected i.p. with pertussis toxin (200 ng/mouse; 
List Biological Laboratories) in PBS. For the Ezh2Mg−/− mice and 
their littermates, 5- to 6-wk-old mice were treated orally with 4 
mg tamoxifen (T5648; Sigma Aldrich) solved in 200 µl corn oil 
(C8267; Sigma Aldrich) via gavage at two time points 48 h apart 
for the induction of Cre recombinase in these Cx3cr1-CreER-
EYFP mice. 1 mo later, tamoxifen-exposed mice were applied for 
the EAE induction. The immunized mice were examined daily 
and scored for disease severity by using the standard method: 
0, no clinical signs; 0.5, partially limp tail; 1, paralyzed tail; 2, 
loss in coordinated movement, hind limb paresis; 2.5, one hind 
limb paralyzed; 3, both hind limbs paralyzed; 3.5, hind limbs 
paralyzed, weakness in forelimbs; 4, forelimbs paralyzed; 5, 
moribund or death. After the onset of EAE, food and water were 
provided on the cage floor.
Bone marrow chimeras
Bone marrow cells (10 × 106) derived from donor mice were i.v. 
injected into lethally irradiated (950 rad) recipient mice. The 
lethal-dose irradiation would eliminate the bone marrow and 
peripheral immune cells without affecting the radioresistant 
CNS-resident cells, thus the chimeric mice would have their 
peripheral immune system reconstituted with bone marrow cells 
derived from donor mice. After 8 wk, the chimeric mice were 
immunized for EAE induction.
Histological analysis
Spinal cords dissected from mice transcardially perfused with 
4% paraformaldehyde were fixed in 4% paraformaldehyde over-
night, embedded in paraffin, and sectioned for staining with 
H&E and Luxol fast blue (LFB).
Isolation and analysis of immune cells from CNS or colon
For preparation of immune cells in the CNS or colon, CNS (brains 
and spinal cords) from naive and MOG35–55-immunized mice or 
colons from naive or DSS-induced colitis mice were excised and 
digested at 37°C with collagenase IV (0.5 mg/ml; Gibco) and 
DNase I (10 µg/ml; Roche) in RPMI 1640. Dispersed cells were 
layered onto a Percoll density gradient and isolated by collection 
of the interface fraction between 37% and 70% Percoll. After 
intensive washing, the frequencies of immune cell subpopula-
tions in the CNS or colon were analyzed by flow cytometry. These 
frequencies were then multiplied by the total cell numbers of the 
Percoll-isolated cells from each mouse to get the absolute num-
bers of immune cell subpopulations. The colonic macrophages 
and CNS microglia were prepared by using the abovementioned 
protocol to collect the Percoll-isolated cells, which were then 
applied for FACS sorting by using specific antibodies against 
related cell markers. Inflammatory gene expression in CNS 
microglia or colonic macrophages was analyzed by qRT-PCR.
Real-time qRT-PCR
Total RNA was isolated by using TRIzol reagent (Invitrogen) and 
subjected to cDNA synthesis. qRT-PCR was performed in trip-
licate by using SYBR Green Supermix (Roche). The expression 
of individual genes was calculated by a standard curve method 
and normalized to the expression of Actb. The gene-specific PCR 
primers (all for mouse genes) are shown in Table S1.
Flow cytometry
Cell suspensions were subjected to flow cytometry analyses as 
previously described (Xiao et al., 2013) by using a Beckman Gal-
lios or BD Aria2 flow cytometer. For the gating strategy, FSC/SSC 
was initially applied to the gate for live cells and then used for the 
antibodies with specific fluorochrome to make the subsequent 
gates. All the samples in the same experiments and comparisons 
were gated under the same parameters.
Cell culture
For culturing the primary microglia, the meninges of the brains 
from newborn mice (1–2 d old) were removed and then dissoci-
ated with 0.25% trypsin at 37°C, filtered with a 70-µm mesh, and 
the cells were cultured in complete DMEM medium. After 2 wk 
of cultivation (with medium changes at 24 h and then every 3 
d), microglia were collected by intensive washing and shaking 
the culture (250 rpm) for 1 h at 37°C. For culturing the primary 
macrophages, bone marrow cells were isolated from femurs and 
tibias of adult mice and cultured for 5 d in a DMEM medium sup-
plemented with macrophage CSF conditional medium.
Immunoblot, immunoprecipitation, and ubiquitination assays
Whole-cell lysates or whole-cell extracts were prepared and sub-
jected to immunoblot (IB) and immunoprecipitation (IP) assays 
as described (Xiao et al., 2013). The samples were resolved by 
8.25% SDS–PAGE. After electrophoresis, separated proteins were 
transferred onto nitrocellulose membrane (Millipore). For IB 
Figure 6. Ezh2 epigenetically controls Socs3 expression in macrophages/microglia. (A) qRT-PCR analysis of the indicated genes in WT and Ezh2-deficient 
macrophages that were pretreated with DMSO or cycloheximide (CHX) for 1 h and then left nontreated (NT) or stimulated with LPS for 6 h. (B) Mean Ezh2 ChIP 
signal in WT macrophages that were left nontreated (NT) or stimulated for 2 h with LPS (100 ng/ml). (C) Heat maps of Input and Ezh2 ChIP-Seq signals at TSSs 
(±3 kb) in WT bone marrow–derived macrophage left nontreated (NT) or stimulated for 2 h with LPS. The source ChIP-Seq data were deposited into the Gene 
Expression Omnibus with the accession no. GSE101320. (D) Venn diagram showing the numbers of genes harboring Ezh2 peaks and displaying up-regulation 
in LPS-stimulated macrophages. (E) Snapshot of the Ezh2 ChIP-Seq signal at the Socs3 loci in WT macrophages left nontreated (NT) or stimulated for 2 h with 
LPS; the arrows indicate the location of the ChIP primer pairs (P1 and P2). (F) ChIP-qPCR analysis of Ezh2 binding to the Socs3 loci in WT macrophages left 
nontreated (NT) or stimulated for 2 h with LPS. (G and H) qRT-PCR and IB analysis of Socs3 mRNA and protein levels in WT and Ezh2-deficient macrophages 
(G, upper panel of H) and Ezh2-KO BV2 cells that infected with EV or lentiviral vector encoding WT Ezh2 (lower panel of H), left nontreated (NT) or stimulated 
with LPS for 6 h (qPCR) or 12 h (IB). The relative expression of Socs3 compared with Hsp60 was quantified and presented below the Socs3 IB panels. (I and J) 
ChIP-qPCR analysis of H3K27me3 (I) and H3K4me3 (J) modifications at the Socs3 loci in WT and Ezh2-deficient macrophages left nontreated (NT) or stimulated 
for 2 h with LPS. The qRT-PCR data were normalized to a reference gene, Actb (β-actin), and other data are shown as mean ± SD based on three independent 
experiments. *, P < 0.05; **, P < 0.01 determined by Student’s t test.
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Figure 7. Ezh2 regulates TRAF6 degradation and its downstream signaling. (A and B) Analysis of TRAF6 Lys48-linked ubiquitination in WT and Ezh2-defi-
cient macrophages (A) or in Ezh2-KO BV2 cell that infected with EV or lentiviral vector encoding WT Ezh2 (B) that was stimulated with LPS at the indicated time 
points. (C–E) IB analysis of TRAF6 protein levels in WT and Ezh2-deficient macrophages (C), in microglia (D), or in Ezh2-KO BV2 cells that were infected with EV 
or lentiviral vector encoding WT Ezh2 (E) that was stimulated without or with LPS at the indicated time points. The relative expression of Traf6 compared with 
loading controls (Actin or Hsp60) was quantified and presented below the Traf6 IB panels. (F and G) qRT-PCR analysis of Traf6 mRNA expression in WT and 
Ezh2-deficient macrophages (F) or microglia (G) that was stimulated with LPS at the indicated time points. (H–K) Immunoblot analysis of phosphorylated (P-) 
and total NF-κB and MAPKs signaling proteins, H3K27me3, H3, Ezh2, or Hsp60 (loading control) in whole-cell lysates of WT and Ezh2-deficient macrophages 
that were left unstimulated or stimulated with LPS (100 ng/ml; H) or Pam3CSK4 (100 ng/ml; I) or poly I:C (pI:C, 20 µg/ml; J), and IB of the indicated signal protein 
in the whole-cell lysates of WT and Ezh2-deficient primary microglia that were left unstimulated or stimulated with LPS (100 ng/ml; K) at the indicated time 
points. The qRT-PCR data were normalized to a reference gene, Actb (β-actin), and other data are shown as mean ± SD based on three independent experiments.
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Figure 8. Inhibition of Socs3 restores autoimmune inflammation in Ezh2-deficient mice. (A) qRT-PCR determining the relative expression of the indicated 
genes in WT and Ezh2-deficient macrophages that infected with retrovirus carrying control vector (shCtr) or Socs3 shRNA (shS3 #1 and shS3 #2), left nontreated 
(NT) or stimulated with LPS for 6 h. (B) Upper panel: scheme of how Socs3 was knocked down in vivo in WT and Ezh2M−/− mice that applied for DSS challenge. 
Lower panel: qRT-PCR determining Socs3 mRNA expression in FACS-sorted colon and spleen immune-cell populations in WT and Ezh2M−/− mice that were i.v. 
injected with retrovirus carrying control vector (shCtrl) or Socs3 shRNA (shSocs3). (C) The body-weight loss of WT and Ezh2M−/− mice that were knocked down 
Socs3 as described in B and then challenged with DSS in drinking water for 7 d. (D) Upper panel: scheme of how Socs3 was knocked down in vivo in WT and 
Ezh2Mg−/− mice that applied for EAE induction. Ta, tamoxifen. Lower panel: qRT-PCR determining Socs3 mRNA expression in FACS-sorted CNS YFP+ microglia 
and spleen CD11b+F4/80+ macrophages in WT (Ezh2+/+Cx3cr1-creER-EYFP+) and Ezh2Mg−/− (Ezh2f/fCx3cr1-creER-EYFP+) mice that were exposed by tamoxifen 
and then were immunized with MOG peptide to induce EAE and i.v. injected with retrovirus carrying control vector (shCtrl) or Socs3 shRNA (shSocs3) at the 
indicated time points. (E) Mean clinical scores of WT and Ezh2Mg−/− mice that were knocked down Socs3 and applied for EAE induction as described in D. (F) H&E 
and LFB staining of spinal cord sections from MOG35–55-immunized mice as described in D, visualizing immune-cell infiltration and demyelinization (arrows), 
respectively. Bars, 100 µm. The qRT-PCR data were normalized to a reference gene, Actb (β-actin), and the other data are shown as mean ± SD based on three 
independent experiments. *, P < 0.05; **, P < 0.01 determined by Student’s t test.
Zhang et al. 
Macrophage/microglia Ezh2 mediates autoimmunity
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20171417
1380
assays, the nitrocellulose membrane was blocked with 5% non-
fat milk, incubated with a specific primary antibody, horseradish 
peroxidase–conjugated secondary antibody, and detected based 
on ECL reactive signal. For Lys48-linked ubiquitination assays, 
the cells were pretreated with MG132 (C2211; Sigma Aldrich) for 
2 h, stimulated with LPS for the indicated time, and then lysed 
for IP followed by detecting ubiquitination by IB by using anti-
Lys48 ubiquitin.
RNA-Seq analysis
Total RNA isolated from WT and Ezh2M−/− macrophages left non-
treated or stimulated with LPS were subjected to HiSeq RNA-Seq 
performed by BGI Tech Solutions. Transcriptomic reads from 
the RNA-Seq experiments were mapped to a reference genome 
(mm10) by using Bowtie. Gene expression levels were quantified 
by using the RSEM software package. Significant genes were 
defined by the p-value and false discovery rate of cutoff of 0.05 
and fold changes ≥1.5. Differentially expressed genes were sub-
sequently analyzed by using the DAV ID bioinformatics platform 
and Ingenuity Pathway Analysis. The genes used for the GO term 
analyses are the up- and down-regulated genes in LPS-stimulated 
WT macrophages versus LPS-stimulated Ezh2-deficient macro-
phages (P < 0.05, fold change ≥ 1.2).
ChIP-Seq assay
The chromatin of WT macrophages left nontreated or treated 
with LPS was prepared and subjected to ChIP-Seq analysis per-
formed by Active Motif. 75 nucleotide reads generated by Illu-
mina sequencing were mapped to the genome by using the BWA 
algorithm with default settings. Only reads that passed the Illu-
mina purity filter, aligned with no more than two mismatches, 
and mapped uniquely to the genome were used in the subsequent 
analysis. The heat maps and average profile for RefSeq gene bod-
ies were generated by using ngsplot v2.61.
CHIP-qPCR
Macrophages (10 × 106) were stimulated for 2 h with LPS, fixed in 
1% formaldehyde, and then sonicated. Lysates were subjected to 
IP with the indicated antibodies, and the precipitated DNA was 
then purified by columns (Millipore) and quantified by qPCR by 
using primers listed in Table S1. The precipitated DNA is pre-
sented as percentage of the total input DNA (y axis).
Figure 9. Model of Ezh2 in the regulation of macrophages/microglia activation and autoimmune inflammation. In WT macrophages/microglia, Ezh2, 
together with EED and Suz12 form PRC2 complex, which directly target Socs3 to promote the H3K27me3 and suppress the expression of Socs3, lead to 
uncontrolled TLR-induced NF-κB activation and increased proinflammatory gene expression, therefore finally promoting the autoimmune inflammation. 
Whereas in Ezh2-deficient cells, Ezh2 depletion caused a substantial reduction of H3K27me3 levels, incensement of H3K4me3 at the Socs3 gene enhancer 
region induced the up-regulation of Socs3. Socs3 in turn mediated the Lys48-linked ubiquitination and degradation of TRAF6, leading to the suppression of 
TLR-induced MyD88-dependent NF-κB activation and the inhibition of genes involved in macrophage/microglial activation and autoimmune inflammation.
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One-way or two-way ANO VA, where applicable, was performed 
to determine whether an overall statistically significant change 
existed before the Student’s t test was used to analyze the differ-
ence between any two groups. Data are presented as means ± SD. 
P < 0.05 was considered statistically significant.
Data availability
Sequencing data are deposited into the Gene Expression Omni-
bus (accession no. GSE101383), which includes RNA-Seq data no. 
GSE101316 and ChIP-Seq data no. GSE101320. Source data files 
for Figs. 4 and 5 are available online, and there is no restriction 
on data availability.
Online supplemental material
Fig. S1 shows that Ezh2 deficiency in macrophages does not affect 
peripheral T cell responses during EAE process and the identifi-
cation of Ezh2 deletion efficiency in microglia of Ezh2Mg−/− mice. 
Fig. S2 shows that Ezh2 deficiency impairs TLR2-mediated proin-
flammatory gene expression in primary cultured macrophages 
and microglia. Fig. S3 shows that Ezh2 deficiency slightly impairs 
M2 macrophage polarization. Fig. S4 shows Ezh2 expression in 
brain samples from non-multiple sclerosis (MS) donors and MS 
patients. Table S1 shows primers used for real-time quantitative 
PCR or CHIP-qPCR.
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